Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases

Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases

Item
http://www.wikidata.org/entity/Q37163756
Preference for pharmaceutical formulation and treatment process attributesHealth state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysisHealth state utilities associated with attributes of treatments for hepatitis C.Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?Intravenous versus Subcutaneous Drug Administration. Which Do Patients Prefer? A Systematic Review.Economic evaluation of rituximab in addition to standard of care chemotherapy for adult patients with acute lymphoblastic leukemia.An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries.Preference-based valuation of treatment attributes in haemophilia A using web survey.PCSK9 Inhibitors Show Value for Patients and the US Health Care System.Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension.
P2860

Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases

Item
http://www.wikidata.org/entity/Q37163756
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Utilities associated with subc ...... patients with bone metastases
@en
Utilities associated with subc ...... patients with bone metastases.
@nl
type
label
Utilities associated with subc ...... patients with bone metastases
@en
Utilities associated with subc ...... patients with bone metastases.
@nl
prefLabel
Utilities associated with subc ...... patients with bone metastases
@en
Utilities associated with subc ...... patients with bone metastases.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P5875
P698
P932
P356
P1433
P1476
Utilities associated with subc ...... patients with bone metastases
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P5875
P698
P932